Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms

Journal of Pathology

Volumn 212, Issue 1, 2007, Pages 20-28

  Houard, X ^a   Rouzet, F ^a   Touat, Z ^a   Phillipe, M ^a   Dominguez, M ^a   Fontaine, V ^a   Sarda Mantel, L ^a   Meulemans, A ^a   Le Guludec, D ^a   Meilhac, O ^a   Michel, J B ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Abdominal aortic aneurysm; Fibrinolytic system; Mural thrombus

Indexed keywords

ALPHA 2 ANTIPLASMIN; APROTININ TC 99M; D DIMER; LIGAND; MESSENGER RNA; PLASMIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERINE PROTEINASE; TECHNETIUM DERIVATIVE; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME RELEASE; EX VIVO STUDY; FIBRINOLYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCINTIGRAPHY; THROMBOGENESIS; THROMBUS;

AGED; AGED, 80 AND OVER; ANTIPLASMIN; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; APROTININ; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYTIC AGENTS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 34248547514     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2148     Document Type: Article

References (39)

1. Satta J, Laara, E, Juvonen T. Intraluminal thrombus predicts rupture of an abdominal aortic aneurysm. J Vasc Surg 1996; 23(4):737-739.
2. Siegel CL, Cohan RH, Korobkin M, Alpern MB, Courneya DL, Leder RA. Abdominal aortic aneurysm morphology: CT features in patients with ruptured and nonruptured aneurysms. Am J Roentgenol 1994; 163(5):1123-1129.
3. Wolf YG, Thomas WS, Brennan FJ, Goff WG, Sise MJ, Bernstein EF. Computed tomography scanning findings associated with rapid expansion of abdominal aortic aneurysms. J Vasc Surg 1994;20(4):529-535; discussion 535-538.
4. Kazi M, Thyberg J, Religa P, Roy J, Eriksson P, Hedin U, et al. Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. J Vasc Surg 2003; 38(6):1283-1292.
5. Touat Z, Ollivier V, Dai J, Huisse MG, Bezeaud A, Sebbag U, et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol 2006; 168(3):1022-1030.
6. Houard X, Leclercq A, Fontaine V, Coutard M, Martin-Ventura JL, Ho-Tin-Noe B, et al. Retention and activation of blood-borne proteases in the arterial wall implications for atherothrombosis. J Am Coll Cardiol 2006;48(9 suppl):A3-9.
7. Fontaine V, Jacob MP, Houard X, Rossignol P, Plissonnier D, Angles-Cano E, et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 2002;161(5):1701-1710.
8. Gacko M, Worowska. A, Glowinski S. Coagulative and fibrinolytic activity in parietal thrombus of aortic aneurysm. Rocz Akad Med Bialymst 1999;44:102-110.
9. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet 2005;365(9470):1577-1589.
10. Lindholt JS, Jorgensen B, Fasting H, Henneberg EW. Plasma levels of plasmin-antiplasmin complexes are predictive for small abdominal aortic aneurysms expanding to operation-recommendable sizes. J Vasc Surg 2001;34(4):611-615.
11. Lindholt JS, Vammen S, Fasting H, Henneberg EW, Heickendorff L. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg 2000;20(3):281-285.
12. Lindholt JS. Activators of plasminogen and the progression of small abdominal aortic aneurysms. Ann N Y Acad Sci 2006; 1085:139-150.
13. Yamazumi K, Ojiro M, Okumura H, Aikou T. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg 1998;175(4):297-301.
14. Fowkes FG, Anandan CL, Lee AJ, Smith FB, Tzoulaki I, Rumley A, et al. Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease. J Vasc Surg 2006;43(3):474-480.
15. Rossignol P, Cambillau M, Mouradian D, Plouin PF, Chatellier G, Jacob MP. Variations with time of plasma concentrations of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2. Thromb Res 2007;119(2):261-263.
16. Fontaine V, Touat Z, Mtairag el M, Vranckx R, Louedec L, Houard X, et al. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am J Pathol 2004;164(6):2077-2087.
17. Lottenberg R, Christensen U, Jackson CM, Coleman PL. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol 1981;80(C):341-361.
18. Houard X, Monnot C, Dive V, Corvol P, Pagano M. Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin. J Cell Biochem 2003; 88(6):1188-1201.
19. Lijnen HR, Van Hoef B, Lupu F, Moons L, Carmeliet P, Collen D. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 1998; 18(7):1035-1045.
20. 99mTc-aprotinin scintigraphy in amyloidosis. J Nucl Med 2003; 44(2):177-183.
21. Petegnief Y, Petiet A, Peker MC, Bonnin F, Meulemans A, Le Guludec D. Quantitative autoradiography using a radioimager based on a multiwire proportional chamber. Phys Med Biol 1998;43(12):3629-3638.
22. Kolev K, Tenekedjiev K, Ajtai K, Kovalszky I, Gombas J, Varadi B, et al. Myosin: a noncovalent stabilizer of fibrin in the process of clot dissolution. Blood 2003;101(11):4380-4386.
23. Kazi M, Zhu C, Roy J, Paulsson-Berne G, Hamsten A, Swedenborg J, et al. Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2005; 25(7):1341-1346.
24. Carrell TW, Burnand KG, Booth NA, Humphries J, Smith A. Intraluminal thrombus enhances proteolysis in abdominal aortic aneurysms. Vascular 2006;14(1):9-16.
25. Sakalihasan N, Delvenne P, Nusgens BV, Limet R, Lapiere CM. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 1996;24(1):127-133.
26. Booth NA, Simpson AJ, Croll A, Bennett B, MacGregor IR. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol 1988;70(3):327-333.
27. Heiple JM, Ossowski L. Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis. J Exp Med 1986;164(3):826-840.
28. Sasajima T, Takano Y, Hiraishi Y, Goh K, Inaba M, Azuma N, et al. High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system. J Vasc Surg 2000;32(2):374-382.
29. Sakharov DV, Rijken DC. Superficial accumulation of plasminogen during plasma clot lysis. Circulation 1995;92(7):1883-1890.
30. Adolph R, Vorp DA, Steed DL, Webster MW, Kameneva MV, Watkins SC. Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm. J Vasc Surg 1997;25(5):916-926.
31. Thorsen S, Glas-Greenwalt P, Astrup T. Differences in the binding to fibrin of urokinase and tissue plasminogen activator. Thromb Diath Haemorrh 1972;28(1):65-74.
32. Podor TJ, Campbell S, Chindemi P, Foulon DM, Farrell DH, Walton PD, et al. Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and γA /γ′ fibrinogen. J Biol Chem 2002; 277(9):7520-7528.
33. Wohn KD, Schmidt T, Kanse SM, Yutzy B, Germer M, Morgenstern E, et al. The role of plasminogen activator inhibitor-1 as inhibitor of platelet and megakaryoblastic cell adhesion. Br J Haematol 1999; 104(4):901-908.
34. Francis CW, Markham RE Jr, Marder VJ. Demonstration of in situ fibrin degradation in pathologic thrombi. Blood 1984; 63(5):1216-1224.
35. Moore KL, Patel KD, Bruehl RE, Li F, Johnson DA, Lichenstein HS, et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 1995;128(4):661-671.
36. Reilly JM, Sicard GA, Lucore CL. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. J Vasc Surg 1994;19(5):865-872.
37. Schneiderman J, Bordin GM, Engelberg I, Adar R, Seiffert D, Tbinnes T, et al. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion. J Clin Invest 1995;96(1):639-645.
38. Melrose J, Ghosh P, Patel M. Biotinylated aprotinin: a versatile probe for the detection of serine proteinases on western blots. Int J Biochem Cell Biol 1995;27(9):891-904.
39. Rustom R, Grime S, Maltby P, Stockdale HR, Critchley M, Bone JM. A new method to measure renal tubular degradation of small filtered proteins in man using radiolabelled aprotinin (Trasylol). Clin Sci (Lond) 1992;83(3):289-294.